chr2-178453495-A-G
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2
The NM_001042702.5(PJVK):āc.86A>Gā(p.Asp29Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000903 in 1,614,054 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D29E) has been classified as Likely benign.
Frequency
Consequence
NM_001042702.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PJVK | NM_001042702.5 | c.86A>G | p.Asp29Gly | missense_variant | 2/7 | ENST00000644580.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PJVK | ENST00000644580.2 | c.86A>G | p.Asp29Gly | missense_variant | 2/7 | NM_001042702.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000998 AC: 152AN: 152232Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00160 AC: 399AN: 249522Hom.: 1 AF XY: 0.00162 AC XY: 219AN XY: 135380
GnomAD4 exome AF: 0.000893 AC: 1305AN: 1461822Hom.: 10 Cov.: 30 AF XY: 0.000917 AC XY: 667AN XY: 727208
GnomAD4 genome AF: 0.000998 AC: 152AN: 152232Hom.: 2 Cov.: 33 AF XY: 0.000981 AC XY: 73AN XY: 74384
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 05, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 13, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Autosomal recessive nonsyndromic hearing loss 59 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 05, 2017 | p.Asp29Gly variant in in exon 7 of DFNB59: This variant is not expected to have clinical significance because it has been identified in 3.1% (318/10150) of Ashk enazi Jewish chromosomes including 1 homozygote by the genome Aggregation Databa se (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs200502817). - |
PJVK-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 27, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at